Home/Pipeline/REC-MSC for Spinal Canal Stenosis

REC-MSC for Spinal Canal Stenosis

Spinal Canal Stenosis

PreclinicalActive

Key Facts

Indication
Spinal Canal Stenosis
Phase
Preclinical
Status
Active
Company

About PuREC

PuREC develops purified mesenchymal stem cell therapies for bone regeneration using its proprietary Rapidly-Expanding Cell (REC) platform.

View full company profile